These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10601880)

  • 1. Opposing effects of estrogen and progestins on LDL oxidation and vascular wall cytotoxicity: implications for atherogenesis.
    Zhu X; Bonet B; Gillenwater H; Knopp RH
    Proc Soc Exp Biol Med; 1999 Dec; 222(3):214-21. PubMed ID: 10601880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol 17beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees.
    Zhu X; Bonet B; Knopp RH
    Atherosclerosis; 2000 Jan; 148(1):31-41. PubMed ID: 10580168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL oxidation and human placental trophoblast and macrophage cytotoxicity.
    Bonet B; Hauge-Gillenwater H; Zhu XD; Knopp RH
    Proc Soc Exp Biol Med; 1998 Feb; 217(2):203-11. PubMed ID: 9452145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
    Mueck AO; Seeger H; Lippert TH
    Clin Exp Obstet Gynecol; 1998; 25(1-2):26-8. PubMed ID: 9841134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are the antioxidative effects of 17 beta-estradiol modified by concomitant administration of a progestin?
    Schröder J; Dören M; Schneider B; Oettel M
    Maturitas; 1996 Oct; 25(2):133-9. PubMed ID: 8905604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells.
    Nègre-Salvayre A; Pieraggi MT; Mabile L; Salvayre R
    Atherosclerosis; 1993 Mar; 99(2):207-17. PubMed ID: 8503949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17beta-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages.
    Zhu XD; Bonet B; Knopp RH
    Am J Obstet Gynecol; 1997 Jul; 177(1):196-209. PubMed ID: 9240607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys.
    Williams JK; Delansorne R; Paris J
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):219-24. PubMed ID: 9699876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular effects and estrogen/gestagen substitution therapy].
    Kuhl H
    Ther Umsch; 1994 Nov; 51(11):748-54. PubMed ID: 7839333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro.
    McManus J; McEneny J; Young IS; Thompson W
    Maturitas; 1996 Oct; 25(2):125-31. PubMed ID: 8905603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
    Botella J; Duranti E; Viader V; Duc I; Delansorne R; Paris J
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):77-84. PubMed ID: 7577723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progestogens, progesterone, coagulation and vascular tone].
    Schved JF; Biron C
    Gynecol Obstet Fertil; 2002 May; 30(5):421-6. PubMed ID: 12087938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys.
    Wagner JD; Zhang L; Williams JK; Register TC; Ackerman DM; Wiita B; Clarkson TB; Adams MR
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1473-80. PubMed ID: 8977451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogens and cardiovascular disease. A critical review.
    Clarkson TB
    J Reprod Med; 1999 Feb; 44(2 Suppl):180-4. PubMed ID: 11392029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins initiate adverse events of menopausal estrogen therapy.
    Thomas T; Rhodin J; Clark L; Garces A
    Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.